Cargando…
Pharmacological inhibition of EZH2 disrupts the female germline epigenome
BACKGROUND: Recently discovered drugs that target epigenetic modifying complexes are providing new treatment options for a range of cancers that affect patients of reproductive age. Although these drugs provide new therapies, it is likely that they will also affect epigenetic programming in sperm an...
Autores principales: | Prokopuk, Lexie, Hogg, Kirsten, Western, Patrick S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836460/ https://www.ncbi.nlm.nih.gov/pubmed/29515677 http://dx.doi.org/10.1186/s13148-018-0465-4 |
Ejemplares similares
-
PRC2 is required for extensive reorganization of H3K27me3 during epigenetic reprogramming in mouse fetal germ cells
por: Prokopuk, Lexie, et al.
Publicado: (2017) -
Reduced PRC2 function alters male germline epigenetic programming and paternal inheritance
por: Stringer, Jessica M., et al.
Publicado: (2018) -
HTLV-1 Tax disrupts the host epigenome by interacting with a Polycomb group protein EZH2
por: Fujikawa, Dai, et al.
Publicado: (2014) -
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013) -
Loss of maternal EED results in postnatal overgrowth
por: Prokopuk, Lexie, et al.
Publicado: (2018)